Researchers from Pritzker Molecular Engineering, under the guidance of Prof. Jeffrey Hubbell, demonstrated that their compound can eliminate the autoimmune response linked to multiple sclerosis. Researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) have developed
This is your initial claim, though.
Also, apologies if I come off as aggressive at any point, I still have a lot of residual anger over what I experienced with my former career.
No, my initial claim was:
Then you opined that whoever comes up with a cure wins, which should be true in a perfect world. In fact, most researchers would agree with you.
Unfortunately, a lot of MBA’s in these pharma companies don’t see it that way, and my reply to you was trying to outline the realities of that. I focussed more on the patent-and-bury part because this is the one method less known to the public (and less used), but underfunding research that can do a public good but isn’t profitable is a common technique by corporations in research, regardless of the discipline.
My bad, I thought this was common knowledge, but it probably isn’t for people who aren’t in PhD/post-doc research roles.